ARMK vs BIO · P/E 40, rev $14.80B vs rev $651.0M
Aramark Holdings (ARMK) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Aramark Holdings (ARMK) is a specialty business services company listed on US.
BIO (BIO) common stock.
Latest reported ARMK revenue for 2026-07-03 was $14.80B. Net income was $295.8M. Revenue was up 51.9% from 2026-04-03 to 2026-07-03. ARMK currently screens at market cap $14.08B and trailing P/E 40.0.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
ARMK currently screens at market cap $14.08B and trailing P/E 40.0. BIO currently screens at market cap $0.
Not investment advice. Open the ARMK and BIO stock pages for the full models.
Not investment advice.